Synergistic self-assembly and crosslinking yield a durable, bioactive, and injectable recombinant collagen implant for photoaging therapy
Regenerative Biomaterials · 22.01.2026 · 13
DOI: 10.1093/rb/rbag026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Regenerative Biomaterials, online erschienen am 02.03.2026. Verfasst von Nannan Wei und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Product Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, PR China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Sustained ultraviolet (UV) irradiation upregulates matrix metalloproteinases (MMPs) activity, exacerbates collagen degradation, and triggers inflammatory signaling, leading to extracellular matrix (ECM) disorganization and skin photoaging. While animal-derived collagens are widely used in clinical applications, their immunogenicity and batch variability limit safety and consistency. Recombinant collagen provides a safer and more controllable alternative. However, poor fibrillogenesis, limited structural stability, and rapid enzymatic degradation hinder long-term performance. Here, we developed an injectable recombinant collagen nanofiber implant (B-SARCI) through the synergistic integration of molecular self-assembly and mild 1,4-butanediol diglycidyl ether (BDDE) crosslinking. This dual strategy preserves excellent injectability while simultaneously enhancing thermal stability, and enzymatic resistance. B-SARCI improved fibroblast attachment and proliferation, promoted migration, and facilitated differentiation in vitro. In a murine UV-induced photoaging model, B-SARCI restored dermal density, enhanced barrier function, and reduced transepidermal water loss (TEWL). Transcriptomic and histological analyses revealed upregulation of Col1α1 and Col3α1, suppression of MMP2, MMP3, and MMP9, and modulation of the JAK-STAT pathway via SOCS3 induction and IL-6 downregulation. Together, these findings demonstrate that B-SARCI re-establishes ECM homeostasis and attenuates inflammation, representing a durable, bioactive, and clinically translatable recombinant collagen implant for photoaged skin repair.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Natural Product Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, PR China.
- Gansu Engineering Research Center of Medical Collagen, Lanzhou 730000, PR China.
- State Key Laboratory of Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou 730000, PR China.
ORCID-Profile: Jianxi Xiao
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wei, N., Zhang, Y., Tian, X., Yao, L., & Xiao, J. (2026). Synergistic self-assembly and crosslinking yield a durable, bioactive, and injectable recombinant collagen implant for photoaging therapy. Regenerative Biomaterials, 13. https://doi.org/10.1093/rb/rbag026
Vancouver
Wei N, Zhang Y, Tian X, Yao L, Xiao J. Synergistic self-assembly and crosslinking yield a durable, bioactive, and injectable recombinant collagen implant for photoaging therapy. Regenerative Biomaterials. 2026;13. doi:10.1093/rb/rbag026
BibTeX
@article{Wei2026,
author = {Wei, Nannan and Zhang, Yuchen and Tian, Xinyu and Yao, Linyan and Xiao, Jianxi},
title = {Synergistic self-assembly and crosslinking yield a durable, bioactive, and injectable recombinant collagen implant for photoaging therapy},
journal = {Regenerative Biomaterials},
year = {2026},
volume = {13},
doi = {10.1093/rb/rbag026}
}
EUVIMED